2-(3,4-DIMETHOXY-BENZYL)-5-METHYL-2H-PYRAZOL-3-YLAMINE
![]() |
- $400 - $874
- Product name: 2-(3,4-DIMETHOXY-BENZYL)-5-METHYL-2H-PYRAZOL-3-YLAMINE
- CAS: 957507-56-1
- MF: C13H17N3O2
- MW: 247.29
- EINECS:
- MDL Number:MFCD07186340
- Synonyms:ASINEX-REAG BAS 06502064;2-(3,4-DIMETHOXY-BENZYL)-5-METHYL-2H-PYRAZOL-3-YLAMINE;TIMTEC-BB SBB011894;2-[(3,4-dimethoxyphenyl)methyl]-5-methylpyrazol-3-amine;1-(3,4-Dimethoxybenzyl)-3-methyl-1H-pyrazol-5-amine;1H-Pyrazol-5-amine, 1-[(3,4-dimethoxyphenyl)methyl]-3-methyl-
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500MG
- 1g
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0088016
- Product description2-(3,4-DIMETHOXY-BENZYL)-5-METHYL-2H-PYRAZOL-3-YLAMINE 95.00%
- Packaging500MG
- Price$777.32
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11003162
- Product description1-(3,4-Dimethoxybenzyl)-3-methyl-1H-pyrazol-5-amine 97%
- Packaging5g
- Price$874
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number018762
- Product description2-(3,4-Dimethoxy-benzyl)-5-methyl-2H-pyrazol-3-ylamine
- Packaging1g
- Price$400
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0088016 | 2-(3,4-DIMETHOXY-BENZYL)-5-METHYL-2H-PYRAZOL-3-YLAMINE 95.00% | 500MG | $777.32 | 2021-12-16 | Buy |
Crysdot | CD11003162 | 1-(3,4-Dimethoxybenzyl)-3-methyl-1H-pyrazol-5-amine 97% | 5g | $874 | 2021-12-16 | Buy |
Matrix Scientific | 018762 | 2-(3,4-Dimethoxy-benzyl)-5-methyl-2H-pyrazol-3-ylamine | 1g | $400 | 2021-12-16 | Buy |
Properties
Boiling point :431.7±45.0 °C(Predicted)
Density :1.19±0.1 g/cm3(Predicted)
pka :4.34±0.10(Predicted)
Density :1.19±0.1 g/cm3(Predicted)
pka :4.34±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|